Purpose

Many youth are addicted to nicotine due to increased nicotine vaping (e.g., e-cigarettes). Unfortunately, there are no effective interventions to help teens quit vaping. In addition, existing vaping prevention programs have limited effectiveness because they are out of touch with teen's culture and are not appealing to the intended audience. Therefore, to be effective, a vaping intervention must be acceptable, appealing, and engaging to teens, and most importantly, it should be designed to be channeled into an existing infrastructure such as the school setting. The investigators' research group has designed a vaping prevention and cessation intervention that is implemented as a VR game for high school teens. The overall objective of this research is to assess the acceptability, feasibility, and preliminary efficacy of the VR experience among high school students in high school in Boston.

Conditions

Eligibility

Eligible Ages
Between 13 Years and 19 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Students enrolled at Public High Schools (freshmen, sophomores, juniors, and seniors). - Must be able to speak and understand English. - Child assents

Exclusion Criteria

  • Teacher indicates that participation is not appropriate for the student (e.g., severe mental illness; visual or auditory disability) - Parent(s)/guardian(s) opt student out of the study. - Prone to motion sickness or seizures. - Blind or otherwise unable to use VR device.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Virtual Reality Program
Students in classrooms randomized to this group will receive the Virtual Reality vaping cessation and prevention program.
  • Behavioral: Virtual Reality Program
    The VR Program will be pre-installed on Meta Quest 2 headsets, which will be donned by students as a class to experience the intervention for approximately the length of one school class period (approximately 45 minutes). Each participant will experience the program once a week for 3 weeks. Participants who missed a week will complete the program by the 4th or 5th week.
    Other names:
    • VR Program
  • Behavioral: Augmented Reality Program
    VR program participants will be able to download an optional mobile app that complements and reinforces the school-based VR session.
No Intervention
Assessment Only
Students in classrooms randomized to this group will not receive the VR intervention but will complete questionnaire assessment only.

Recruiting Locations

Boston University, Goldman School of Dental Medicine
Boston, Massachusetts 02118
Contact:
Daniel Weinstein, MSc
617-358-3358
dweinst1@bu.edu

More Details

Status
Recruiting
Sponsor
Boston University

Study Contact

Belinda Borrelli, PhD
(617) 358-3358
belindab@bu.edu

Detailed Description

The investigators will conduct a randomized trial (N=150) of high school students (freshman to seniors) in the Boston area to determine feasibility, satisfaction, and preliminary efficacy of the VR-based vaping cessation and prevention game. Students will be randomized by class to either receive the VR program (experimental condition) or control condition (questionnaire assessment only). There will be three VR sessions played at school during a health class. Participants in the VR condition will also engage in a gamified home-based component on their smartphone, in order to reinforce skills learned in the school-based VR experience. For every 4 - 5 classes enrolled in the VR condition, two will be enrolled in the control condition. Participants will be enrolled in the study for approximately 5 weeks. In the first 3 weeks, participants will engage in the VR game experience once per week during their classes. In the fourth and fifth week, participants may make up any VR game session that they missed because of absence (e.g., illness). At week 5, participants will complete the follow-up questionnaire assessments.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.